645
Views
8
CrossRef citations to date
0
Altmetric
Reviews

Overview of the potent cyanobacterial neurotoxin β-methylamino-L-alanine (BMAA) and its analytical determination

, , &
Pages 1570-1586 | Received 10 Jun 2016, Accepted 15 Jul 2016, Published online: 22 Sep 2016

References

  • Al-Sammak M, Hoagland K, Cassada D, Snow D. 2014. Co-occurrence of the cyanotoxins BMAA, DABA and anatoxin-a in Nebraska reservoirs, fish, and aquatic plants. Toxins. 6:488–508.
  • Al-Sammak MA, Hoagland KD, Snow DD, Cassada D. 2013. Methods for simultaneous detection of the cyanotoxins BMAA, DABA, and anatoxin-a in environmental samples. Toxicon. 76:316–325.
  • Ambrogelly A, Palioura S, Söll D. 2007. Natural expansion of the genetic code. Nat Chem Biol. 3:29–35.
  • Azevedo SMFO, Carmichael WW, Jochimsen EM, Rinehart KL, Lau S, Shaw GR, Eaglesham GK. 2002. Human intoxication by microcystins during renal dialysis treatment in Caruaru—Brazil. Toxicology. 181–182:441–446.
  • Banack SA, Caller T, Henegan P, Haney J, Murby A, Metcalf JS, Powell J, Cox PA, Stommel E. 2015. Detection of cyanotoxins, β-N-methylamino-L-alanine and microcystins, from a lake surrounded by cases of amyotrophic lateral sclerosis. Toxins. 7:322–336.
  • Banack SA, Caller TA, Stommel EW. 2010a. The cyanobacteria derived toxin beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis. Toxins. 2:2837–2850.
  • Banack SA, Cox PA, Murch SJ, Fleming T, Racey P. 2010b. Flying fox consumption and human neurodegenerative disease in Guam. Chicago (IL): University of Chicago Press.
  • Banack SA, Downing TG, Spácil Z, Purdie EL, Metcalf JS, Downing S, Esterhuizen M, Codd GA, Cox PA. 2010c. Distinguishing the cyanobacterial neurotoxin β-N-methylamino-l-alanine (BMAA) from its structural isomer 2,4-diaminobutyric acid (2,4-DAB). Toxicon. 56:868–879.
  • Banack SA, Johnson HE, Cheng R, Cox PA. 2007. Production of the neurotoxin BMAA by a marine cyanobacterium. Marine Drugs. 5:180–196.
  • Banack SA, Metcalf JS, Spáčil Z, Downing TG, Downing S, Long A, Nunn PB, Cox PA. 2011. Distinguishing the cyanobacterial neurotoxin β-N-methylamino-l-alanine (BMAA) from other diamino acids. Toxicon. 57:730–738.
  • Banack SA, Murch SJ, Cox PA. 2006. Neurotoxic flying foxes as dietary items for the Chamorro people, Marianas Islands. J Ethnopharmacol. 106:97–104.
  • Berntzon L, Ronnevi LO, Bergman B, Eriksson J. 2015. Detection of BMAA in the human central nervous system. Neuroscience. 292:137–147.
  • Blenis J, Resh MD. 1993. Subcellular localization specified by protein acylation and phosphorylation. Curr Opin Cell Biol. 5:984–989.
  • Boniface A, Parquet C, Arthur M, Mengin-Lecreulx D, Blanot D. 2009. The elucidation of the structure of Thermotoga maritima peptidoglycan reveals two novel types of cross-link. J Biol Chem. 284:21856–21862.
  • Bradley WG, Mash DC. 2009. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases. Amyotroph Lateral Scler. 10:7–20.
  • Brand LE, Pablo J, Compton A, Hammerschlag N, Mash DC. 2010. Cyanobacterial blooms and the occurrence of the neurotoxin, beta-N-methylamino-l-alanine (BMAA), in South Florida aquatic food webs. Harmful Algae. 9:620–635.
  • Brownson DM, Mabry TJ, Leslie SW. 2002. The cycad neurotoxic amino acid, ß-N-methylamino-l-alanine (BMAA), elevates intracellular calcium levels in dissociated rat brain cells. J Ethnopharmacol. 82:159–167.
  • Butler N, Carlisle J, Linville R, Washburn B. 2009. Microcystins: a brief overview of their toxicity and effects, with special reference to fish, wildlife, and livestock. Sacramento: California Environmental Protection Agency; p. 5.
  • Cervantes Cianca RC, Baptista MS, Da Silva LP, Lopes VR, Vasconcelos VM. 2012. Reversed-phase HPLC/FD method for the quantitative analysis of the neurotoxin BMAA (β-N-methylamino-l-alanine) in cyanobacteria. Toxicon. 59:379–384.
  • Chiu AS, Gehringer MM, Braidy N, Guillemin GJ, Welch JH, Neilan BA. 2013. Gliotoxicity of the cyanotoxin, [bgr]-methyl-amino-L-alanine (BMAA). Sci Rep. 3:1482. doi:10.1038/srep01482
  • Christensen SJ, Hemscheidt TK, Trapido-Rosenthal H, Laws EA, Bidigare RR. 2012. Detection and quantification of β-methylamino-L-alanine in aquatic invertebrates. Limnol Oceanogr Methods. 10:891–898.
  • Cohen SA. 2012. Analytical techniques for the detection of α-amino-β-methylaminopropionic acid. Analyst. 137:1991–2005.
  • Cox PA, Banack SA, Murch SJ. 2003. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proc Natl Acad Sci. 100:13380–13383.
  • Cox PA, Banack SA, Murch SJ, Rasmussen U, Tien G, Bidigare RR, Metcalf JS, Morrison LF, Codd GA, Bergman B. 2005. Diverse taxa of cyanobacteria produce β-N-methylamino-L-alanine, a neurotoxic amino acid. Proc Natl Acad Sci USA. 102:5074–5078.
  • Cox PA, Richer R, Metcalf JS, Banack SA, Codd GA, Bradley WG. 2009. Cyanobacteria and BMAA exposure from desert dust: a possible link to sporadic ALS among Gulf War veterans. Amyotroph Lateral Scler. 10:109–117.
  • Crine P, Lemieux E. 1982. Incorporation of canavanine into rat pars intermedia proteins inhibits the maturation of pro-opiomelanocortin, the common precursor to adrenocorticotropin and beta-lipotropin. J Biol Chem. 257:832–838.
  • Cross GA. 1987. Eukaryotic protein modification and membrane attachment via phosphatidylinositol. Cell. 48:179–181.
  • De Munck E, Muñoz-Sáez E, Miguel BG, Solas MT, Martínez A, Arahuetes RM. 2015. Morphometric and neurochemical alterations found in l-BMAA treated rats. Environ Toxicol Pharmacol. 39:1232–1245.
  • Devries S, Galey F, Namikoshi M, Woo J. 1993. Clinical and pathologic findings of blue-green algae (Microcystis aeruginosa) intoxication in a dog. J Vet Diagn Investig. 5:403–408.
  • Downing S, Banack SA, Metcalf JS, Cox PA, Downing TG. 2011. Nitrogen starvation of cyanobacteria results in the production of β-N-methylamino-L-alanine. Toxicon. 58:187–194.
  • Downing S, Contardo-Jara V, Pflugmacher S, Downing TG. 2014. The fate of the cyanobacterial toxin β-N-methylamino-l-alanine in freshwater mussels. Ecotoxicol Environ Saf. 101:51–58.
  • Downing S, Esterhuizen-Londt M, Grant Downing T. 2015. β-N-methylamino-L-alanine (BMAA) metabolism in the aquatic macrophyte Ceratophyllum demersum. Ecotoxicol Environ Saf. 120:88–92.
  • Duncan MW, Steele JC, Kopin IJ, Markey SP. 1990. 2‐Amino‐3‐(methylamino)‐propanoic acid (BMAA) in cycad flour an unlikely cause of amyotrophic lateral sclerosis and parkinsonism‐dementia of Guam. Neurology. 40:767.
  • Dunlop R, Rodgers K. 2011. Proteins containing BMAA generate autofluorescent aggregates and induce cell death [poster]. 22nd Annual Symposium on ALS/MND; Sydney, Australia.
  • Dunlop RA, Cox PA, Banack SA, Rodgers KJ. 2013. The non-protein amino acid BMAA is misincorporated into human proteins in place of L-serine causing protein misfolding and aggregation. Plos One. 8:e75376.
  • Eriksson J, Jonasson S, Papaefthimiou D, Rasmussen U, Bergman B. 2009. Improving derivatization efficiency of BMAA utilizing AccQ-Tag® in a complex cyanobacterial matrix. Amino Acids. 36:43–48.
  • Esterhuizen-Londt M, Downing S, Downing T. 2011. Improved sensitivity using liquid chromatography mass spectrometry (LC-MS) for detection of propyl chloroformate derivatised β-N-methylamino-L-alanine (BMAA) in cyanobacteria. Water SA. 37:133–138.
  • Esterhuizen-Londt M, Downing T. 2011. Solid phase extraction of beta (B)-N-methylamino-L-alanine (BMAA) from South African water supplies. Water SA. 37:523–528.
  • Esterhuizen-Londt M, Wiegand C, Downing TG. 2015. β-N-methylamino-l-alanine (BMAA) uptake by the animal model, Daphnia magna and subsequent oxidative stress. Toxicon. 100:20–26.
  • Esterhuizen M, Downing TG. 2008. β-N-methylamino-l-alanine (BMAA) in novel South African cyanobacterial isolates. Ecotoxicol Environ Saf. 71:309–313.
  • Esterhuizen M, Pflugmacher S, Downing TG. 2011. β-N-Methylamino-l-alanine (BMAA) uptake by the aquatic macrophyte Ceratophyllum demersum. Ecotoxicol Environ Saf. 74:74–77.
  • Faassen EJ, Gillissen F, Lürling M. 2012. A comparative study on three analytical methods for the determination of the neurotoxin BMAA in cyanobacteria. Plos One. 7:e36667.
  • Haass C, Selkoe DJ. 2007. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid β-peptide. Nat Rev Mol Cell Biol. 8:101–112.
  • Harada K-I, Tsuji K, Watanabe MF, Kondo F. 1996. Stability of microcystins from cyanobacteria-III.* Effect of pH and temperature. Phycologia. 35:83–88.
  • Holtcamp W. 2012. The emerging science of BMAA: do cyanobacteria contribute to neurodegenerative disease? Environ Health Perspect. 120:A110–A116.
  • Jiang L, Aigret B, De Borggraeve W, Spacil Z, Ilag L. 2012. Selective LC-MS/MS method for the identification of BMAA from its isomers in biological samples. Anal Bioanal Chem. 403:1719–1730.
  • Jiao Y, Chen Q, Chen X, Wang X, Liao X, Jiang L, Wu J, Yang L. 2014. Occurrence and transfer of a cyanobacterial neurotoxin β-methylamino-l-alanine within the aquatic food webs of Gonghu Bay (Lake Taihu, China) to evaluate the potential human health risk. Sci Total Environ. 468–469:457–463.
  • Johnson HE, King SR, Banack SA, Webster C, Callanaupa WJ, Cox PA. 2008. Cyanobacteria (Nostoc commune) used as a dietary item in the Peruvian highlands produce the neurotoxic amino acid BMAA. J Ethnopharmacol. 118:159–165.
  • Jonasson S, Eriksson J, Berntzon L, Spáčil Z, Ilag LL, Ronnevi L-O, Rasmussen U, Bergman B. 2010. Transfer of a cyanobacterial neurotoxin within a temperate aquatic ecosystem suggests pathways for human exposure. Proc Natl Acad Sci. 107:9252–9257.
  • Karlsson O, Jiang L, Andersson M, Ilag LL, Brittebo EB. 2014. Protein association of the neurotoxin and non-protein amino acid BMAA (β-N-methylamino-l-alanine) in the liver and brain following neonatal administration in rats. Toxicol Lett. 226:1–5.
  • Karlsson O, Lindquist NG, Brittebo EB, Roman E. 2009. Selective brain uptake and behavioral effects of the cyanobacterial toxin BMAA (β-N-methylamino-L-alanine) following neonatal administration to rodents. Toxicol Sci. 109:286–295.
  • Krüger T, Mönch B, Oppenhäuser S, Luckas B. 2010. LC-MS/MS determination of the isomeric neurotoxins BMAA (β-N-methylamino-l-alanine) and DAB (2,4-diaminobutyric acid) in cyanobacteria and seeds of Cycas revoluta and Lathyrus latifolius. Toxicon. 55:547–557.
  • Kubo T, Kato N, Hosoya K, Kaya K. 2008. Effective determination method for a cyanobacterial neurotoxin, β-N-methylamino-l-alanine. Toxicon. 51:1264–1268.
  • Lage S, Burian A, Rasmussen U, Costa PR, Annadotter H, Godhe A, Rydberg S. 2015. BMAA extraction of cyanobacteria samples: which method to choose? Environ Sci and Pollut Res. 23:1–13.
  • Li A, Tian Z, Li J, Yu R, Banack SA, Wang Z. 2010. Detection of the neurotoxin BMAA within cyanobacteria isolated from freshwater in China. Toxicon. 55:947–953.
  • Lobner D. 2011. Synergistic toxicity of the environmental neurotoxins methylmercury and beta-N-methylamino-L-alanine (BMAA). 22nd Annual Symposium on ALS/MND; Sydney, Australia.
  • Lobner D, Piana PMT, Salous AK, Peoples RW. 2007. β-N-methylamino-l-alanine enhances neurotoxicity through multiple mechanisms. Neurobiol Dis. 25:360–366.
  • Lürling M, Faassen EJ, Van Eenennaam JS. 2011. Effects of the cyanobacterial neurotoxin β-N-methylamino-l-alanine (BMAA) on the survival, mobility and reproduction of Daphnia magna. J Plankton Res. 33:333–342.
  • Marler TE, Snyder LR, Shaw CA. 2010. Cycas micronesica (Cycadales) plants devoid of endophytic cyanobacteria increase in β-methylamino-l-alanine. Toxicon. 56:563–568.
  • Mcdaniel CN, Holterman RK, Bone RF, Wozniak PM. 1982. Amino acid transport in suspension-cultured plant cells: III. Common carrier system for the uptake of L-arginine, L-aspartic acid, L-histidine, L-leucine, and L-phenylalanine. Plant Physiol. 69:246–249.
  • Ministry for the Environment NZ. 2016. Chemical and physical determinands. p. 3.
  • Mondo K, Hammerschlag N, Basile M, Pablo J, Banack SA, Mash DC. 2012. Cyanobacterial neurotoxin β-N-methylamino-L-alanine (BMAA) in shark fins. Mar Drugs. 10:509–520.
  • Murch S, Cox P, Banack S, Steele J, Sacks O. 2004a. Occurrence of β‐methylamino‐l‐alanine (BMAA) in ALS/PDC patients from Guam. Acta Neurol Scand. 110:267–269.
  • Murch SJ, Cox PA, Banack SA. 2004b. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. Proc Natl Acad Sci USA. 101:12228–12231.
  • Neilan BA, Dittmann E, Rouhiainen L, Bass RA, Schaub V, Sivonen K, Börner T. 1999. Nonribosomal peptide synthesis and toxigenicity of cyanobacteria. J Bacteriol. 181:4089–4097.
  • Oehrle SA, Southwell B, Westrick J. 2010. Detection of various freshwater cyanobacterial toxins using ultra-performance liquid chromatography tandem mass spectrometry. Toxicon. 55:965–972.
  • Pablo J, Banack SA, Cox PA, Johnson TE, Papapetropoulos S, Bradley WG, Buck A, Mash DC. 2009. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer’s disease. Acta Neurol Scand. 120:216–225.
  • Rao SD, Banack SA, Cox PA, Weiss JH. 2006. BMAA selectively injures motor neurons via AMPA/kainate receptor activation. Exp Neurol. 201:244–252.
  • Richer R, Banack SA, Metcalf JS, Cox PA. 2015. The persistence of cyanobacterial toxins in desert soils. J Arid Environ. 112:134–139.
  • Rodgers K, Dunlop R. 2011. The cyanobacteria-derived neurotoxin BMAA can be incorporated into cell proteins and could thus be an environmental trigger for ALS and other neurological diseases associated with protein misfolding. 22nd Annual Symposium on ALS/MND; Sydney, Australia.
  • Rosén J, Hellenäs K-E. 2008. Determination of the neurotoxin BMAA (β-N-methylamino-L-alanine) in cycad seed and cyanobacteria by LC-MS/MS (liquid chromatography tandem mass spectrometry). Analyst. 133:1785–1789.
  • Rosenthal G. 2001. L-canavanine: a higher plant insecticidal allelochemical. Amino Acids. 21:319–330.
  • Rush T, Liu X, Lobner D. 2012. Synergistic toxicity of the environmental neurotoxins methylmercury and β-N-methylamino-L-alanine. Neuroreport. 23:216–219.
  • Seebach D, Studer A, Pfammatter E, Widmer H. 1994. Synthesis of tri‐, penta‐, and heptapeptides containing and (R)‐2‐alkyl‐2‐amino‐3‐(methylamino)‐propionic acid residue in the central position. Helvetica Chimica Acta. 77:2035–2050.
  • Soto C. 2003. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci. 4:49–60.
  • Spacil Z, Eriksson J, Jonasson S, Rasmussen U, Ilag LL, Bergman B. 2010. Analytical protocol for identification of BMAA and DAB in biological samples. Analyst. 135:127–132.
  • Spencer P, Ludolph A, Dwivedi M, Roy D, Hugon J, Schaumburg H. 1986. Lathyrism: evidence for role of the neuroexcitatory amino acid BOAA. Lancet. 328:1066–1067.
  • Spencer PS, Kisby GE, Ludolph AC. 1991. Slow toxins, biologic markers, and long‐latency neurodegenerative disease in the western Pacific region. Neurology. 41:62–66.
  • Spencer PS, Nunn PB, Hugon J, Ludolph AC, Ross SM, Roy DN, Robertson RC. 1987. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science. 237:517–522.
  • Vance JM, Ali S, Bradley WG, Singer C, Di Monte DA. 2010. Gene–environment interactions in Parkinson’s disease and other forms of parkinsonism. Neurotoxicology. 31:598–602.
  • Vega A, Bell EA. 1967. α-Amino-β-methylaminopropionic acid, a new amino acid from seeds of Cycas circinalis. Phytochemistry. 6:759–762.
  • Weiss JH, Koh J-Y, Choi DW. 1989. Neurotoxicity of β-N-methylamino-l-alanine (BMAA) and β-N-oxalylamino-l-alamine (BOAA) on cultured cortical neurons. Brain Research. 497:64–71.
  • Whiting MG. 1963. Toxicity of cycads. Econ Bot. 17:270–302.
  • WHO. 2011. Guidelines for drinking-water quality. World Health Organization. 216:303–304.
  • Wyse RE, Komor E. 1984. Mechanism of amino acid uptake by sugarcane suspension cells. Plant Physiol. 76:865–870.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.